These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6671363)

  • 1. Abnormal alanine aminotransferase level in blood units from donors in Montreal does not indicate high risk of transmitting hepatitis.
    Steinbrecher UP; Kovacs TO; Gelly A; Tourigny M
    Clin Invest Med; 1983; 6(4):327-30. PubMed ID: 6671363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.
    Aach RD; Szmuness W; Mosley JW; Hollinger FB; Kahn RA; Stevens CE; Edwards VM; Werch J
    N Engl J Med; 1981 Apr; 304(17):989-94. PubMed ID: 6782484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum alanine aminotransferase levels among volunteer blood donors: effect of sex, alcohol intake and obesity.
    Bizzaro N; Tremolada F; Casarin C; Bonetti P; Noventa F; Diodati G; Drago C; Realdi G
    Ital J Gastroenterol; 1992 Jun; 24(5):237-41. PubMed ID: 1623221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers.
    Cleavinger PJ; Persing DH; Li H; Moore SB; Charlton MR; Sievers C; Therneau TM; Zein NN
    Am J Gastroenterol; 2000 Mar; 95(3):772-6. PubMed ID: 10710073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor transaminase and recipient hepatitis. Impact on blood transfusion services.
    Alter HJ; Purcell RH; Holland PV; Alling DW; Koziol DE
    JAMA; 1981 Aug; 246(6):630-4. PubMed ID: 6788964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alanine aminotransferase (ALAT, GPT): a reevaluation of exclusion limits for blood donors].
    Grunenberg R; Banik N; Krüger J
    Infusionsther Transfusionsmed; 1995 Jun; 22(3):145-51. PubMed ID: 7640509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of alanine aminotransferase in blood donor screening--evidence of its usefulness in the prevention of post-transfusion hepatitis.
    Khouri ST; Lopes EP; Perez RM; Figueiredo VM; Lanzoni VP; Silva AE; Ferraz ML
    Clin Lab; 2004; 50(5-6):291-4. PubMed ID: 15209437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus.
    Fukuda S; Sunaga J; Saito N; Fujimura K; Itoh Y; Sasaki M; Tsuda F; Takahashi M; Nishizawa T; Okamoto H
    J Med Virol; 2004 Aug; 73(4):554-61. PubMed ID: 15221899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated ALT activity in volunteer blood donors.
    Fernández Carbia A
    Bol Asoc Med P R; 1991 May; 83(5):185-8. PubMed ID: 1930470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of serum alanine-aminotransferase levels in blood donors in Spain.
    Lozano M; Cid J; Bedini JL; Mazzara R; Gimenez N; Mas E; Ballesta A; Ordinas A
    Haematologica; 1998 Mar; 83(3):237-9. PubMed ID: 9573678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of donor alanine aminotransferase testing. Implications for the blood donor and practitioner.
    Saxena S; Korula J; Shulman IA
    Arch Pathol Lab Med; 1989 Jul; 113(7):767-71. PubMed ID: 2500923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of elevated alanine aminotransferase in blood donors: a follow-up study.
    Torezan-Filho MA; Alves VA; Neto CA; Fernandes HS; Strauss E
    Liver Int; 2004 Dec; 24(6):575-81. PubMed ID: 15566507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase.
    Sakata H; Matsubayashi K; Takeda H; Sato S; Kato T; Hino S; Tadokoro K; Ikeda H
    Transfusion; 2008 Dec; 48(12):2568-76. PubMed ID: 18774966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor serum alanine aminotransferase activity and the risk of transfusion-associated hepatitis.
    Lenes BA; Tomasulo P; Alter HJ; Holland PV
    N Engl J Med; 1983 Mar; 308(12):723. PubMed ID: 6402702
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors.
    N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203
    [No Abstract]   [Full Text] [Related]  

  • 17. Posttransfusion hepatitis: clinical features, risk and donor testing.
    Alter HJ
    Prog Clin Biol Res; 1985; 182():47-61. PubMed ID: 3929262
    [No Abstract]   [Full Text] [Related]  

  • 18. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan.
    Matsubayashi K; Nagaoka Y; Sakata H; Sato S; Fukai K; Kato T; Takahashi K; Mishiro S; Imai M; Takeda N; Ikeda H
    Transfusion; 2004 Jun; 44(6):934-40. PubMed ID: 15157263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transfusion viral hepatitis and the TTVS.
    Holland PV; Bancroft W; Zimmerman H
    N Engl J Med; 1981 Apr; 304(17):1033-5. PubMed ID: 6782483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.